Alternatively, TREM2 may be a marker of Aβ-induced tau pathology and neurodegeneration in AD (Park et al., 2021), supporting the notion that microglial activation may drive tau pathology (Pascoal et al., 2021). This evidence concerns the gene TREM2 and Alzheimer disease.